Global Intramuscular Immune Globulin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 84901
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

The Intramuscular Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Intramuscular Immune Globulin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Intramuscular Immune Globulin market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Intramuscular Immune Globulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

10mL Vial

2.0mL Vial

Market segment by Application can be divided into

Hepatitis A

Measles

Others

The key market players for global Intramuscular Immune Globulin market are listed below:

Grifols Therapeutics

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Intramuscular Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Intramuscular Immune Globulin, with price, sales, revenue and global market share of Intramuscular Immune Globulin from 2019 to 2021.

Chapter 3, the Intramuscular Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Intramuscular Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Intramuscular Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Intramuscular Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Intramuscular Immune Globulin Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Intramuscular Immune Globulin Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 10mL Vial

1.2.3 2.0mL Vial

1.3 Market Analysis by Application

1.3.1 Overview: Global Intramuscular Immune Globulin Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hepatitis A

1.3.3 Measles

1.3.4 Others

1.4 Global Intramuscular Immune Globulin Market Size & Forecast

1.4.1 Global Intramuscular Immune Globulin Sales in Value (2016-2026))

1.4.2 Global Intramuscular Immune Globulin Sales in Volume (2016-2026)

1.4.3 Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)

1.5 Global Intramuscular Immune Globulin Production Capacity Analysis

1.5.1 Global Intramuscular Immune Globulin Total Production Capacity (2016-2026)

1.5.2 Global Intramuscular Immune Globulin Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Intramuscular Immune Globulin Market Drivers

1.6.2 Intramuscular Immune Globulin Market Restraints

1.6.3 Intramuscular Immune Globulin Trends Analysis

2 Manufacturers Profiles

2.1 Grifols Therapeutics

2.1.1 Grifols Therapeutics Details

2.1.2 Grifols Therapeutics Major Business

2.1.3 Grifols Therapeutics Intramuscular Immune Globulin Product and Services

2.1.4 Grifols Therapeutics Intramuscular Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Intramuscular Immune Globulin Sales by Manufacturer

3.1 Global Intramuscular Immune Globulin Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Intramuscular Immune Globulin Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Intramuscular Immune Globulin

3.4 Market Concentration Rate

3.4.1 Top 3 Intramuscular Immune Globulin Manufacturer Market Share

3.4.2 Top 6 Intramuscular Immune Globulin Manufacturer Market Share

3.5 Global Intramuscular Immune Globulin Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Intramuscular Immune Globulin Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Intramuscular Immune Globulin Market Size by Region

4.1.1 Global Intramuscular Immune Globulin Sales in Volume by Region (2016-2026)

4.1.2 Global Intramuscular Immune Globulin Revenue by Region (2016-2026)

4.2 North America Intramuscular Immune Globulin Revenue (2016-2026)

4.3 Europe Intramuscular Immune Globulin Revenue (2016-2026)

4.4 Asia-Pacific Intramuscular Immune Globulin Revenue (2016-2026)

4.5 South America Intramuscular Immune Globulin Revenue (2016-2026)

4.6 Middle East and Africa Intramuscular Immune Globulin Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Intramuscular Immune Globulin Sales in Volume by Type (2016-2026)

5.2 Global Intramuscular Immune Globulin Revenue by Type (2016-2026)

5.3 Global Intramuscular Immune Globulin Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Intramuscular Immune Globulin Sales in Volume by Application (2016-2026)

6.2 Global Intramuscular Immune Globulin Revenue by Application (2016-2026)

6.3 Global Intramuscular Immune Globulin Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Intramuscular Immune Globulin Sales by Type (2016-2026)

7.2 North America Intramuscular Immune Globulin Sales by Application (2016-2026)

7.3 North America Intramuscular Immune Globulin Market Size by Country

7.3.1 North America Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)

7.3.2 North America Intramuscular Immune Globulin Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Intramuscular Immune Globulin Sales by Type (2016-2026)

8.2 Europe Intramuscular Immune Globulin Sales by Application (2016-2026)

8.3 Europe Intramuscular Immune Globulin Market Size by Country

8.3.1 Europe Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)

8.3.2 Europe Intramuscular Immune Globulin Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Intramuscular Immune Globulin Sales by Type (2016-2026)

9.2 Asia-Pacific Intramuscular Immune Globulin Sales by Application (2016-2026)

9.3 Asia-Pacific Intramuscular Immune Globulin Market Size by Region

9.3.1 Asia-Pacific Intramuscular Immune Globulin Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Intramuscular Immune Globulin Sales by Type (2016-2026)

10.2 South America Intramuscular Immune Globulin Sales by Application (2016-2026)

10.3 South America Intramuscular Immune Globulin Market Size by Country

10.3.1 South America Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)

10.3.2 South America Intramuscular Immune Globulin Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Intramuscular Immune Globulin Sales by Type (2016-2026)

11.2 Middle East & Africa Intramuscular Immune Globulin Sales by Application (2016-2026)

11.3 Middle East & Africa Intramuscular Immune Globulin Market Size by Country

11.3.1 Middle East & Africa Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Intramuscular Immune Globulin Typical Distributors

12.3 Intramuscular Immune Globulin Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Intramuscular Immune Globulin Revenue by Type, (USD Million), 2021-2026

Table 2. Global Intramuscular Immune Globulin Revenue by Application, (USD Million), 2021-2026

Table 3. Grifols Therapeutics Basic Information, Manufacturing Base and Competitors

Table 4. Grifols Therapeutics Major Business

Table 5. Grifols Therapeutics Intramuscular Immune Globulin Product and Services

Table 6. Grifols Therapeutics Intramuscular Immune Globulin Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Global Intramuscular Immune Globulin Sales by Manufacturer (2019-2021e) & (Kiloton)

Table 8. Global Intramuscular Immune Globulin Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 9. Market Position of Manufacturers in Intramuscular Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 10. Global Intramuscular Immune Globulin Production Capacity by Company, (Kiloton): 2020 VS 2021

Table 11. Head Office and Intramuscular Immune Globulin Production Site of Key Manufacturer

Table 12. Intramuscular Immune Globulin New Entrant and Capacity Expansion Plans

Table 13. Intramuscular Immune Globulin Mergers & Acquisitions in the Past Five Years

Table 14. Global Intramuscular Immune Globulin Sales by Region (2016-2021e) & (Kiloton)

Table 15. Global Intramuscular Immune Globulin Sales by Region (2021-2026) & (Kiloton)

Table 16. Global Intramuscular Immune Globulin Revenue by Region (2016-2021e) & (USD Million)

Table 17. Global Intramuscular Immune Globulin Revenue by Region (2021-2026) & (USD Million)

Table 18. Global Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 19. Global Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 20. Global Intramuscular Immune Globulin Revenue by Type (2016-2021e) & (USD Million)

Table 21. Global Intramuscular Immune Globulin Revenue by Type (2021-2026) & (USD Million)

Table 22. Global Intramuscular Immune Globulin Price by Type (2016-2021e) & (US$/Ton)

Table 23. Global Intramuscular Immune Globulin Price by Type (2021-2026) & (US$/Ton)

Table 24. Global Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 25. Global Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 26. Global Intramuscular Immune Globulin Revenue by Application (2016-2021e) & (USD Million)

Table 27. Global Intramuscular Immune Globulin Revenue by Application (2021-2026) & (USD Million)

Table 28. Global Intramuscular Immune Globulin Price by Application (2016-2021e) & (US$/Ton)

Table 29. Global Intramuscular Immune Globulin Price by Application (2021-2026) & (US$/Ton)

Table 30. North America Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)

Table 31. North America Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)

Table 32. North America Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)

Table 33. North America Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)

Table 34. North America Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 35. North America Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 36. North America Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 37. North America Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 38. Europe Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)

Table 39. Europe Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)

Table 40. Europe Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)

Table 41. Europe Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)

Table 42. Europe Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 43. Europe Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 44. Europe Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 45. Europe Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 46. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2016-2021e) & (Kiloton)

Table 47. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2021-2026) & (Kiloton)

Table 48. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2016-2021e) & (USD Million)

Table 49. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2021-2026) & (USD Million)

Table 50. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 51. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 52. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 53. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 54. South America Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)

Table 55. South America Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)

Table 56. South America Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)

Table 57. South America Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)

Table 58. South America Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 59. South America Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 60. South America Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 61. South America Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 62. Middle East & Africa Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)

Table 63. Middle East & Africa Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)

Table 64. Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)

Table 65. Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)

Table 66. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)

Table 67. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)

Table 68. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)

Table 69. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)

Table 70. Direct Channel Pros & Cons

Table 71. Indirect Channel Pros & Cons

Table 72. Intramuscular Immune Globulin Typical Distributors

Table 73. Intramuscular Immune Globulin Typical Customers

List of Figures

Figure 1. Intramuscular Immune Globulin Picture

Figure 2. Global Intramuscular Immune Globulin Sales Market Share by Type in 2020

Figure 3. 10mL Vial

Figure 4. 2.0mL Vial

Figure 5. Global Intramuscular Immune Globulin Sales Market Share by Application in 2020

Figure 6. Hepatitis A

Figure 7. Measles

Figure 8. Others

Figure 9. Global Intramuscular Immune Globulin Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026

Figure 10. Global Intramuscular Immune Globulin Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Intramuscular Immune Globulin Sales (2016-2026) & (Kiloton)

Figure 12. Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)

Figure 13. Global Intramuscular Immune Globulin Production Capacity (2016-2026) & (Kiloton)

Figure 14. Global Intramuscular Immune Globulin Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Intramuscular Immune Globulin Market Drivers

Figure 16. Intramuscular Immune Globulin Market Restraints

Figure 17. Intramuscular Immune Globulin Market Trends

Figure 18. Global Intramuscular Immune Globulin Sales Market Share by Manufacturer in 2020

Figure 19. Global Intramuscular Immune Globulin Revenue Market Share by Manufacturer in 2020

Figure 20. Intramuscular Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)

Figure 24. Global Intramuscular Immune Globulin Revenue Market Share by Region (2016-2026)

Figure 25. North America Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)

Figure 26. Europe Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)

Figure 28. South America Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)

Figure 30. Global Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)

Figure 31. Global Intramuscular Immune Globulin Revenue Market Share by Type (2016-2026)

Figure 32. Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)

Figure 33. Global Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 34. Global Intramuscular Immune Globulin Revenue Market Share by Application (2016-2026)

Figure 35. Global Intramuscular Immune Globulin Price by Application (2016-2026) & (US$/Ton)

Figure 36. North America Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)

Figure 37. North America Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 38. North America Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)

Figure 39. North America Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)

Figure 40. United States Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)

Figure 44. Europe Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 45. Europe Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)

Figure 46. Europe Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)

Figure 47. Germany Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Intramuscular Immune Globulin Revenue Market Share by Region (2016-2026)

Figure 56. China Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)

Figure 63. South America Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 64. South America Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)

Figure 65. South America Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source